IPQ Inside the global regulatory dialogue

OOS Result Handling Continues as Dominant Theme in FDA Warning Letters Issued Abroad

Jun 17th, 2011

Please Log in to print the full article

Giving adequate attention to out-of-specification (OOS) results in batch release decision making and investigation follow up continues as the dominant theme in 2011 in GMP warning letters issued to foreign companies by FDA’s drug and...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications